How do adaptogens in functional drinks affect the body's stress response system?

The HPA axis regulates the cortisol stress response: the hypothalamus releases CRH → the pituitary releases ACTH → the adrenal glands release cortisol. This cascade is essential for survival responses (fight-or-flight) but damaging when chronically activated by modern psychological stressors. The hallmarks of chronic HPA over-activation include elevated baseline cortisol, disrupted circadian rhythm, impaired immune function, fat accumulation, and neurological effects including anxiety and depression.

Ashwagandha (withanolides) appear to act at multiple HPA axis levels. In a rigorous 2019 double-blind RCT, ashwagandha root extract (240mg standardised) reduced serum cortisol by 22.2% over 60 days, with significant improvements in anxiety and stress scores. The withanolide compounds in ashwagandha also modulate GABA receptors (contributing to anxiolytic effects independent of HPA axis) and reduce the inflammatory cytokines (IL-6, TNF-α) that are elevated by chronic stress. (Source: Abdou et al., BioFactors, 2006)

Rhodiola rosea operates through a different primary mechanism. Its active compounds (rosavin and salidroside) stimulate synthesis of neuropeptide Y and Hsp70 (heat shock protein 70), cellular stress proteins that buffer against oxidative stress damage in neurons. This explains rhodiola's specific efficacy for cognitive fatigue: it doesn't sedate, it protects neuronal function under load. Multiple clinical trials show improved performance on cognitive tasks under stress conditions after rhodiola supplementation.

The "normalisation" property is pharmacologically distinctive. Animal studies with adaptogens repeatedly demonstrate that the same compound raises hormone levels in depleted states and reduces them in over-activated states. This is mechanistically different from a cortisol blocker or a stimulant, it's genuinely regulatory. The challenge for functional drinks is delivering adaptogens at doses sufficient to activate these regulatory mechanisms (typically 200–600mg for ashwagandha, 200–400mg for rhodiola) within an appealing beverage format.

How do adaptogens interact with the HPA axis stress cascade?

Adaptogens work primarily by modulating the hypothalamic-pituitary-adrenal (HPA) axis — the body's central stress-response system — and by influencing heat shock protein and nitric oxide pathways. Rather than suppressing or amplifying the stress response, adaptogens help "normalise" it: blunting excessive activation while supporting appropriate stress reactivity. This bidirectional regulation is what distinguishes adaptogens from simple sedatives or stimulants.

The hypothalamic-pituitary-adrenal (HPA) axis is the body's central stress regulation system. When a stressor is perceived, the hypothalamus releases corticotropin-releasing hormone (CRH), which signals the pituitary to release adrenocorticotropic hormone (ACTH), which in turn triggers cortisol secretion from the adrenal glands. Sustained activation of this cascade correlates with impaired immune function, disrupted sleep architecture, and increased cardiovascular risk, according to WHO technical reports on non-communicable disease prevention. (Source: WHO, 2023)

Adaptogens are theorised to operate via two primary mechanisms. First, upregulation of Hsp70 (heat shock protein 70), which reduces the stress-induced expression of NO synthase, thereby lowering pro-inflammatory nitric oxide production. Second, direct inhibition of NF-kB, the transcription factor that drives cortisol synthesis upstream. These mechanisms were characterised in a 2010 review by Panossian and Wikman published in Pharmaceuticals, which analysed 47 pharmacological studies on adaptogenic plants.

Ashwagandha specifically appears to reduce cortisol via direct modulation of CRH receptor sensitivity. A 2021 randomised, double-blind, placebo-controlled trial in Medicine (n=60) showed 240mg/day of standardised ashwagandha extract reduced morning cortisol by 22.2% at 60 days. Rhodiola's primary active compounds, salidroside and rosavin, appear to influence serotonin and dopamine transport rather than the HPA axis directly, which may explain its reputation for energy and mood support rather than pure cortisol reduction.

An important distinction for functional beverage consumers: acute stress response management requires fast-acting mechanisms, whereas adaptogens primarily operate through chronic low-dose regulation. This makes them more appropriate as daily preventive tools than emergency calming agents, distinguishing them clearly from acute-acting compounds like L-theanine, which shows measurable alpha-wave increases on EEG within 45 minutes of ingestion at 200mg (Nobre et al., Asia Pacific Journal of Clinical Nutrition, 2008).

The practical implication: adaptogen functional drinks are best evaluated over weeks of consistent use, not individual servings. A 30-day diary approach alongside a validated stress questionnaire such as the PSS-10 (Perceived Stress Scale) represents a reasonable personal assessment protocol, consistent with study designs used in published RCTs on ashwagandha.

Finally, the chronobiology of cortisol matters for optimal adaptogen timing. Cortisol follows a diurnal rhythm with a peak (the cortisol awakening response, or CAR) within 30-45 minutes of waking. This is the point of highest HPA axis activity. Several adaptogen studies have timed dosing to coincide with this peak, finding that morning administration before or with breakfast produces the most measurable cortisol-modulating effects. Consuming adaptogen beverages in the morning therefore has a stronger mechanistic rationale than evening consumption.

Related questions